Cite
Josiassen J, Helgestad OKL, Udesen NLJ, et al. Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure. J Cardiovasc Transl Res. 2021;14(6):1021-1029doi: 10.1007/s12265-021-10131-x.
Josiassen, J., Helgestad, O. K. L., Udesen, N. L. J., Banke, A., Frederiksen, P. H., Schmidt, H., Jensen, L. O., Hassager, C., Møller, J. E., & Ravn, H. B. (2021). Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure. Journal of cardiovascular translational research, 14(6), 1021-1029. https://doi.org/10.1007/s12265-021-10131-x
Josiassen, Jakob, et al. "Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure." Journal of cardiovascular translational research vol. 14,6 (2021): 1021-1029. doi: https://doi.org/10.1007/s12265-021-10131-x
Josiassen J, Helgestad OKL, Udesen NLJ, Banke A, Frederiksen PH, Schmidt H, Jensen LO, Hassager C, Møller JE, Ravn HB. Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure. J Cardiovasc Transl Res. 2021 Dec;14(6):1021-1029. doi: 10.1007/s12265-021-10131-x. Epub 2021 May 11. PMID: 33977379.
Copy
Download .nbib